Back to Search
Start Over
Cancer Targeted Therapy Strategy: The Pathologist’s Perspectives
- Publication Year :
- 2018
-
Abstract
- The effectiveness of new personalized treatment procedures in oncology is based on the fact that certain tumors exhibit specific molecular features. More in detail, neoplastic tissues of patients should display a specific biomarker, most often a specific genetic alteration and/or under/overexpression of a definite protein, that could be the target of its respective drug. Immunohistochemical and molecular analyses, which usually include examination of nucleic acids from either tissues or fluids, are common tests to define the status of a tumor. This review focuses on the pathologist’s role in carefully controlling pre- analytic procedures and standard operating procedures that are a crucial prerequisite to reach reliable and reproducible results. Six paradigmatic applications of targeted therapy, for which pathological diagnosis plays a fundamental role, are summarized. Traditional and next-generation sequencing are also addressed from the pathologist's perspective as well as the importance pathologists have in this shift to more accurate definition of disease risk and prognostication of therapy response in the personalized medicine era.
- Subjects :
- 0301 basic medicine
Cancer Research
Pathology
medicine.medical_specialty
molecular analyse
Operating procedures
medicine.medical_treatment
Antineoplastic Agents
Target therapy
biomarker
pathologist's perspective
Immunohistochemistry
FFPE tissue
molecular analyses
traditional sequencing
next-generation sequencing
Biomarker
Molecular analyses
Next-generation sequencing
Pathologist’s perspective
Traditional sequencing
Targeted therapy
03 medical and health sciences
0302 clinical medicine
Neoplasms
Drug Discovery
medicine
Humans
Molecular Targeted Therapy
Precision Medicine
Pharmacology
business.industry
Cancer
Genetic Alteration
medicine.disease
Prognosis
Biomarker (cell)
Neoplasm Proteins
Pathologists
030104 developmental biology
Therapy response
Oncology
030220 oncology & carcinogenesis
Disease risk
Personalized medicine
business
Subjects
Details
- Language :
- English
- Database :
- OpenAIRE
- Accession number :
- edsair.doi.dedup.....158244d17ae471f1241e719a808725d4